XML 63 R48.htm IDEA: XBRL DOCUMENT
v3.6.0.2

SEGMENT INFORMATION (Tables) | 12 Months Ended
--- | ---
Oct. 31, 2016
Revenue from External Customer [Line Items] |
Segment profitability | The profitability of each of the segments is measured after excluding restructuring and asset impairment charges, investment gains and losses, interest income, interest expense, acquisition and integration costs, non-cash amortization and other items as noted in the reconciliations below.
| Life Sciences and Applied Markets |  | Diagnostics and Genomics |  | Agilent CrossLab |  | Total Segments
| (in millions)
Year ended October 31, 2016: |  |  |  |  |  |  |
Total net revenue | $ | 2,073 |  |  | $ | 709 |  |  | $ | 1,420 |  |  | $ | 4,202 |
Income from operations | $ | 429 |  |  | $ | 114 |  |  | $ | 316 |  |  | $ | 859 |
Depreciation expense | $ | 36 |  |  | $ | 31 |  |  | $ | 28 |  |  | $ | 95 |
Share-based compensation expense | $ | 29 |  |  | $ | 10 |  |  | $ | 21 |  |  | $ | 60 |
Year ended October 31, 2015: |  |  |  |  |  |  |
Total net revenue | $ | 2,046 |  |  | $ | 662 |  |  | $ | 1,330 |  |  | $ | 4,038 |
Income from operations | $ | 380 |  |  | $ | 88 |  |  | $ | 299 |  |  | $ | 767 |
Depreciation expense | $ | 27 |  |  | $ | 37 |  |  | $ | 34 |  |  | $ | 98 |
Share-based compensation expense | $ | 27 |  |  | $ | 9 |  |  | $ | 18 |  |  | $ | 54 |
Year ended October 31, 2014: |  |  |  |  |  |  |
Total net revenue | $ | 2,078 |  |  | $ | 663 |  |  | $ | 1,307 |  |  | $ | 4,048 |
Income from operations | $ | 369 |  |  | $ | 93 |  |  | $ | 301 |  |  | $ | 763 |
Depreciation expense | $ | 29 |  |  | $ | 43 |  |  | $ | 33 |  |  | $ | 105 |
Share-based compensation expense | $ | 29 |  |  | $ | 9 |  |  | $ | 18 |  |  | $ | 56 |
Reconciliation of segment results to total enterprise results | The following table reconciles reportable segments' income from operations to Agilent's total enterprise income before taxes:
| Years Ended October 31,
| 2016 |  | 2015 |  | 2014
| (in millions)
Total reportable segments' income from operations | $ | 859 |  |  | $ | 767 |  |  | $ | 763 |
Restructuring and business exit related costs | (11 | ) |  | (12 | ) |  | (66 | )
Asset Impairments | (4 | ) |  | (3 | ) |  | (4 | )
Transformational programs | (38 | ) |  | (56 | ) |  | (29 | )
Amortization of intangibles | (152 | ) |  | (156 | ) |  | (189 | )
Acquisition and integration costs | (41 | ) |  | (13 | ) |  | (11 | )
Acceleration of share-based compensation expense related to workforce reduction | — |  |  | (2 | ) |  | (1 | )
One-time and pre-separation costs | — |  |  | — |  |  | (14 | )
Pension curtailment gain | 16 |  |  | — |  |  | — |
Impairment of loans | (7 | ) |  | — |  |  | — |
Other | (7 | ) |  | (3 | ) |  | 10 |
Interest Income | 11 |  |  | 7 |  |  | 9 |
Interest Expense | (72 | ) |  | (66 | ) |  | (110 | )
Other income (expense), net | (10 | ) |  | 17 |  |  | (89 | )
Unallocated corporate charges | — |  |  | — |  |  | (40 | )
Income before taxes, as reported | $ | 544 |  |  | $ | 480 |  |  | $ | 229 |
Assets and capital expenditures directly managed by each segment | The following table presents assets and capital expenditures directly managed by each segment. Unallocated assets primarily consist of cash, cash equivalents, accumulated amortization of other intangibles and other assets.
| Life Sciences and Applied Markets |  | Diagnostics and Genomics |  | Agilent CrossLab |  | Total Segments
| (in millions)
As of October 31, 2016: |  |  |  |  |  |  |
Assets | $ | 1,687 |  |  | $ | 1,960 |  |  | $ | 1,082 |  |  | $ | 4,729 |
Capital expenditures | $ | 53 |  |  | $ | 41 |  |  | $ | 45 |  |  | $ | 139 |
As of October 31, 2015: |  |  |  |  |  |  |
Assets | $ | 1,539 |  |  | $ | 2,027 |  |  | $ | 1,008 |  |  | $ | 4,574 |
Capital expenditures | $ | 28 |  |  | $ | 33 |  |  | $ | 37 |  |  | $ | 98 |
The following table reconciles segment assets to Agilent's total assets:
| October 31,
| 2016 |  | 2015
| (in millions)
Total reportable segments' assets | $ | 4,729 |  |  | $ | 4,574 |
Cash, cash equivalents and short-term investments | 2,289 |  |  | 2,003 |
Short-term restricted cash and cash equivalents | — |  |  | 242 |
Prepaid expenses | 92 |  |  | 105 |
Investments | 135 |  |  | 86 |
Long-term and other receivables | 92 |  |  | 104 |
Other | 465 |  |  | 365 |
Total assets | $ | 7,802 |  |  | $ | 7,479 |
Revenue by product category | The following table represents total revenue by product category:
| Years Ended October 31,
| 2016 |  | 2015 |  | 2014
| (in millions)
Instrumentation | $ | 1,871 |  |  | $ | 1,827 |  |  | $ | 1,839 |
Analytical lab services | 910 |  |  | 843 |  |  | 831 |
Analytical lab consumables | 510 |  |  | 489 |  |  | 476 |
Diagnostics and genomics solutions | 709 |  |  | 662 |  |  | 663 |
Informatics and other | 202 |  |  | 217 |  |  | 239 |
Total | $ | 4,202 |  |  | $ | 4,038 |  |  | $ | 4,048 |
Revenue and assets by geographic areas | The following table presents summarized information for net revenue and long-lived assets by geographic region. Revenues from external customers are generally attributed to countries based upon the customer's location. Long lived assets consist of property, plant, and equipment, long-term receivables and other long-term assets excluding intangible assets. The rest of the world primarily consists of rest of Asia and Europe.
| United States |  | China |  | Rest of the World |  | Total
| (in millions)
Net revenue: |  |  |  |  |  |  |
Year ended October 31, 2016 | $ | 1,251 |  |  | $ | 821 |  |  | $ | 2,130 |  |  | $ | 4,202 |
Year ended October 31, 2015 | $ | 1,206 |  |  | $ | 633 |  |  | $ | 2,199 |  |  | $ | 4,038 |
Year ended October 31, 2014 | $ | 1,019 |  |  | $ | 543 |  |  | $ | 2,486 |  |  | $ | 4,048 |
| United States |  | Germany |  | Rest of the World |  | Total
| (in millions)
Long-lived assets: |  |  |  |  |  |  |
October 31, 2016 | $ | 449 |  |  | $ | 89 |  |  | $ | 266 |  |  | $ | 804 |
October 31, 2015 | $ | 391 |  |  | $ | 64 |  |  | $ | 315 |  |  | $ | 770 |

X
- Definition Tabular disclosure of the total assets and capital expenditures for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References No definition available. + Details
Name: | a_AssetsAndCapitalExpendituresDirectlyManagedByEachSegmentTableTextBlock
Namespace Prefix: | a_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599 + Details
Name: | us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9031-108599 + Details
Name: | us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9038-108599 + Details
Name: | us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8813-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8721-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8736-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration